期刊文献+

老年2型糖尿病患者并发冠心病的危险因素分析 被引量:23

Analysis on the major risk factors of elderly type 2 diabetes mellitus complicated by coronary heart disease
原文传递
导出
摘要 目的应用主成分分析法(principal component analysis,PCA)分析老年2型糖尿病患者并发冠心病的主要危险因素。方法回顾性分析我院住院行冠状动脉(冠脉)造影检查的60岁以上老年2型糖尿病患者503例临床资料,测定糖尿病患者尿白蛋白排泄率(urinary albuminexcretion rate,UAER)等指标,采用Gensini系统对冠脉血管病变程度进行评分。结果第1~7主成分的特征值均大于1,累计贡献率为64.6%;第1~4主成分分别为UAER、血脂、血压、尿酸,贡献率分别为14.1%、11.8%、10.2%、8.7%;第5~7主成分均属血糖,累计贡献率为19.8%。结论UAER是老年2型糖尿病患者并发冠心病最主要的危险因素,伴微量白蛋白尿的老年2型糖尿病患者冠心病患病风险增加,且严重程度增加;UAER与老年2型糖尿病患者冠心病的发生及冠脉病变严重程度呈正相关,为其独立影响因素。 Objective To analyze the major risk factors of elderly type 2 diabetes mellitus (T2DM) complexing with coronary heart disease(CHD) via principal component analysis (PCA). Methods The clinical data of 503 subjects aged 〉 60 years with T2DM were retrospectively analyzed. Urinary albumin excretion rate(UAER) from urine collected from 10:00 PM to 6:00 AM was measured by chemiluminescence. The degree of angiostegnosis was evaluated by Judkins coronary arteriography and Oensini score. According to UAER level, the patients were divided into microalbuminuria group (20 mg/L〈UAER〈200 rag/L, n= 226) and normal urinary albumin group (UAER〈20 rag/L, n=277). PCA was used to discuss the major risk factors to affect T2DM patients with CHD in the elderly. Results Characteristic values of the principal component from first to seventh were all more than 1, their cumulative rate was 64.7%. The first to fourth principal components and their variances were UAER(14.1%), blood fat (11.8%), blood pressure(10.2%) and uric acid(8.7%), respectively. The fifth to seventh principal components were all blood glucose and the cumulative variance was 19.8%. The numbers of angiostegnosis were 36.5 % single, 34.7 double and 28.9% three in patients with normal urinary albumin, while 10. 20% single, 27.9% double and 61.9 % three in patients with microalbuminuria, respectively(P〈0.05). The Gensini scores was increased in microalbuminuria group (50.7±35.8) as compared with normal urinary albumin group (19.7±23.0) (P〈0.05). UAER was independently related to Gensini scores (β= 0. 442, P= 0. 000). Conclusions UAER is the most important factor of elderly T2DM complexing with CHD and positively correlated with severity of CHD as its independent factor.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2012年第4期286-289,共4页 Chinese Journal of Geriatrics
关键词 糖尿病 2型 冠心病 主成分分析 白蛋白尿 Diabetes mellitus, type 2 Coronary disease Principal component analysis Albuminuria
  • 相关文献

参考文献14

  • 1Macmahon S,Peto R,Cutler J. Blood pressure,stroke,and coronary heart disease:part 1,prolonged differences in blood pressure:prospective observational studies corrected for the regression dilution bias[J].The Lancet,1990.765-774.
  • 2殷樱,陈庆伟,吴庆,柯大智,李桂琼,邓玮.代谢综合征与冠心病的相关性研究[J].中华老年医学杂志,2007,26(8):572-575. 被引量:3
  • 3Kim KS,Koh JM,Song KH. Incidence of overt proteinuria and coronary artery disease in patients with type 2 diabetes mellitus:the role of microalbuminuria and retinopathy[J].Diabetes Research and Clinical Practice,2004.159-165.
  • 4Reboldi G,Gentile G,Angeli F. Microalbuminuria and hypertension[J].Minerva Medica,2005.261-275.
  • 5De Zeeuw D,Remuzzi G,Parring HH. Albuminuria、 a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy[J].Circulation,2004.921-927.
  • 6Dumau D,Demirtunc R,Karadag B. Association of albuminuria with impaired aortic elasticity and left ventricular diastolic dysfunction in type 2 diabetes[J].Anadolu Kardiyoloji Dergisi=the Anatolian Journal of Cardiology,2008.10-15.
  • 7Mogensen CE. Microalbuminuria,blood pressure and diabetes renal disease,origin and development of ideas[J].Diabetologia,1999,(3):263-285.doi:10.1007/s001250051151.
  • 8Temelkova Kurktschiev,Hanefeld M. The lipid triad in type 2 diabetes-prevalence and relevance of hypertriglyceridaemia/low high density lipoprotein syndrome in type 2 diabetes[J].Experimental and Clinical Endocrinology & Diabetes,2004.75-79.
  • 9Turner RC,Holman RR,Matthews DR. Hypertension in Diabetes Study (HDS):ⅡIncreased risk of cardiovascular complications in hypertensive type 2 diabetic patients[J].Journal of Hypertension,1993.319-325.
  • 10UK Prospective Diabetes Study (UKPDS) Group. Intensivc blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J].The Lancet,1998.837-853.

二级参考文献17

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3046
  • 2黄玮,陈庆伟,雷寒,邓玮,柯大智.纤维蛋白原与高敏C反应蛋白对稳定性冠心病患者心血管事件的预测价值[J].中华心血管病杂志,2006,34(8):718-721. 被引量:34
  • 3Reaven GM. Banting lecture 1988: role of insulin resistance in human disease. Diabetes, 1998, 37: 1595-1607.
  • 4Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1 : diagnosis and classification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med, 1998, 15: 539-553.
  • 5Alexander CM. The coming of age of the metabolic syndrome. Diabetes Care, 2003, 26:3180-3181.
  • 6Seeman TE, McEwen BS, Rowe JW, et al. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci USA, 2001, 98:4770-4775.
  • 7中华人民共和国卫生部疾病控制司.中国成人超重和肥胖症预防控制指南,北京:人民卫生出版社.2003.41.
  • 8ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention-Summary Article: A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Pereutaneous Coronary Intervention). Circulation,2006, 113: 156-175.
  • 9He Y, Jiang B, Wang J, et al. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol, 2006, 18;47:1588-1594.
  • 10Gorter PM, Olijhoek JK, Graaf Y, et al. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm. Atherosclerosis, 2004, 173: 363-369.

共引文献2

同被引文献195

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华糖尿病杂志,2010,2(1). 被引量:525
  • 2刘欣,赵秀兰,康毅.糖尿病大鼠心肌细胞凋亡及凋亡相关蛋白表达研究[J].中国心血管杂志,2005,10(1):4-7. 被引量:20
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 4ValkamaJO,Huikuri HV,Koistinen MJ,et al.Relation between heart rate variability and spontaneous and induced ventricular arrhythmias in patients with coronary artery disease.J Am Coll Cardiol,1995,25:437-441.
  • 5Schmidt G,Bauer A,Barthel P,et al.Risk prediction by heart rate turbulence and deceleration capacity in post infarction patients with preserved left ventricular function retrospective analysis of 4 independent trials.J Electrocardiol,2009,42:597-601.
  • 6Cannon CP, Shah S, Dansky HM, et al. Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med, 2010, 363: 2406-2415.
  • 7Kaptoge S, Di Angelantonio E, Lowe G, et al. C- reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant recta-analysis. Lancet, 2010, 375.. 132- 140.
  • 8Polonsky TS, McClelland RL, Jorgensen NW, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA, 2010, 303: 1610-1616.
  • 9Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically Ⅲ patients. JAMA, 2009, 301: 489-499.
  • 10Pandharipande PP, Sanders RD, Girard TD, et al. Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Crit Care, 2010, 14: 1-12.

引证文献23

二级引证文献155

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部